A miRNA-based Diagnostic Model Predicts Resectable Lung Cancer in Humans With High Accuracy

Communications Biology - United States
doi 10.1038/s42003-020-0863-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Cautious Optimism for Induction Immunotherapy in Resectable Lung Cancer

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

A miRNA-based Signature Predicts Development of Disease Recurrence in HER2 Positive Breast Cancer After Adjuvant Trastuzumab-Based Treatment

Scientific Reports
Multidisciplinary
2016English

A Plasma miRNA Signature for Lung Cancer Early Detection

Oncotarget
Oncology
2017English

Volatile Anesthetic Sevoflurane Suppresses Lung Cancer Cells and miRNA Interference in Lung Cancer Cells

OncoTargets and Therapy
OncologyPharmacology
2018English

Prognostic Evaluation of Patients With Resectable Lung Cancer Using Systemic Inflammatory Response Parameters

Oncology Letters
Cancer ResearchOncology
2018English

Neoadjuvant Crizotinib in Resectable Locally Advanced Non-Small-Cell Lung Cancer With ALK-rearrangement: A Brief Report

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

Neoadjuvant Nivolumab Safe, Led to Major Response Rates in Resectable Lung Cancer

Cancer
Cancer ResearchOncology
2018English

A Decision Model of Therapy for Potentially Resectable Pancreatic Cancer

Journal of Surgical Research
Surgery
2012English

High Physician Concern About Malpractice Risk Predicts More Aggressive Diagnostic Testing in Office-Based Practice

Health Affairs
MedicineHealth Policy
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy